GE HealthCare has introduced Revolution RT, a groundbreaking radiation therapy computed tomography (CT) solution, aimed at enhancing imaging accuracy and simplifying simulation workflows for oncology care. Revolution RT, announced at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2024 Congress in Glasgow, features innovative hardware and software solutions designed to personalize and streamline the oncology care pathway, ensuring more effective and timely treatment for patients.
The new Revolution RT is complemented by an updated version of the Intelligent Radiation Therapy (iRT) platform, enhanced with artificial intelligence (AI) capabilities and interfacing with the Spectronic Magnetic resonance imaging (MRI) Planner. GE HealthCare's recent acquisition of the MIM Software portfolio further strengthens its offerings, providing clinicians with improved flexibility, automation, and efficiency in radiation oncology. With a commitment to advancing oncology treatment through AI-driven technologies, GE HealthCare aims to revolutionize the care continuum, delivering personalized and connected care to improve patient outcomes globally.
